Surgical Robots Market (2026 - 2033)

Surgical Robots Market Summary

The global surgical robots market size was valued at USD 14.1 billion in 2025 and is projected to grow from USD 17.2 billion in 2026 to USD 45.6 billion by 2033, at a CAGR of 14.9% from 2026 to 2033. North America dominated the market, accounting for the largest share of 47.0% in 2025. The growth of the industry is driven by the rising adoption of robotic-assisted minimally invasive procedures, the increasing demand for surgical precision, and the growing use of advanced robotic instruments and accessories across hospitals and surgical centers.

Surgical Robots Market Driver Analysis

1) Expanding Adoption of Robotic-Assisted Minimally Invasive Surgery across Specialties

The surgical robots market is being driven by the growing adoption of robotic-assisted minimally invasive procedures across general surgery, urology, gynecology, orthopedics, thoracic, cardiac, and spine applications. Hospitals are increasingly deploying robotic platforms to improve surgical precision, visualization, instrument control, surgeon ergonomics, and patient recovery outcomes.

The adoption trend is supported by rising procedure volumes and expanding installed bases. In 2025, Intuitive Surgical reported that da Vinci procedures increased by 18% to over 3.1 million globally, including 15% growth in the U.S. and 23% growth internationally. The company also placed 1,721 da Vinci systems during the year and ended 2025 with more than 11,100 da Vinci systems installed globally. In addition, the da Vinci 5 platform recorded strong early adoption, with more than 1,200 systems installed across the U.S., Korea, Japan, and Europe, and over 270,000 procedures performed by year-end 2025

2) Technological Advancements in Robotic Surgery Platforms

Technological advancements in imaging, navigation, AI-enabled planning, fluorescence imaging, and robotic instrumentation are strengthening the adoption of surgical robots. These innovations help improve intraoperative visualization, procedural accuracy, surgeon control, and workflow efficiency across complex minimally invasive procedures.

Companies are increasingly integrating advanced visualization and decision-support tools into robotic platforms. For instance, in February 2024, CMR Surgical launched vLimeLite, an integrated fluorescence imaging system designed to improve intraoperative visualization using indocyanine green, helping surgeons assess blood flow and tissue perfusion more effectively.

In addition, in February 2026, Medtronic received U.S. FDA clearance for its Stealth AXiS surgical system for spine procedures. The platform integrates surgical planning, real-time navigation, and robotic assistance into a single system and is designed for use across hospitals and ambulatory surgery centers. Such developments indicate a shift toward intelligent, connected robotic platforms that support broader clinical adoption and improve surgical workflow efficiency.

The growing procedural use of robotic platforms further reflects increasing clinical acceptance. In January 2026, the American College of Surgeons reported that more than 12 million surgeries had been performed globally using da Vinci systems, highlighting the expanding role of robotic surgery in improving outcomes, reducing recovery time, and supporting minimally invasive care.

Surgical Robots Market Restraint Analysis: High Cost Associated with Devices

The surgical robots market faces significant cost-related challenges that are likely to hinder broader adoption, especially in healthcare settings with tight budgets. These robots typically entail substantial upfront costs, as well as expenses for installation, integration, and operating room modifications. Hospitals must also account for recurring costs such as maintenance contracts, software upgrades, and disposable instruments per procedure. In price-sensitive markets and mid-sized healthcare facilities, these costs limit adoption despite clinical benefits.

Source: Secondary Research, Grand View Research

Surgical Robots Market Opportunity Analysis: Expansion of Cross-Border Telesurgery and Remote Intervention

The expansion of telesurgery and remote robotic intervention is creating a significant growth opportunity for the surgical robots market. Advances in 5G, low-latency connectivity, satellite communication, and robotic control systems are enabling surgeons to perform procedures remotely, improving access to specialized surgical care in rural, underserved, and cross-border settings.

This trend is particularly relevant in markets facing shortages of specialist surgeons and limited access to advanced tertiary care. Remote robotic surgery can reduce the need for patient travel, enable faster access to critical procedures, and create new service models centered on centralized telesurgery hubs.

For instance, in April 2025, SS Innovations performed robotic cardiac telesurgery using the SSi Mantra 3 system, connecting Gurugram with Aster CMI Hospital in Bengaluru. In November 2025, the company also introduced MantrAsana, a portable tele-surgeon console designed to support remote procedures without requiring a full operating room setup. Such developments indicate that connectivity and latency barriers are gradually being addressed, supporting the commercial potential of telesurgery in the coming years.

Product Pipeline Analysis, By Stage

New Surgical Robotics Platforms Emerging Globally

Market Concentration & Characteristics

The surgical robots market is characterized by a high degree of innovation. The latest technological advancements in medical robotic systems include improved articulation, tremor filtration, and visualization, enabling surgeons to conduct intricate procedures with unparalleled accuracy and minimal tissue damage. For instance, in July 2025, Wockhardt Hospitals Mira Road launched the MISSO Robotic System for advanced robotic-assisted knee replacement surgeries in India. The system was introduced to enhance surgical precision, minimize tissue damage, support faster recovery, and improve post-operative outcomes for orthopedic patients undergoing minimally invasive knee replacement procedures.

The surgical robots industry is characterized by moderate merger and acquisition activity, owing to several factors, including the desire to expand the business to cater to the growing demand for robotics surgery to maintain a competitive edge. In August 2024, Karl Storz completed its acquisition of Asensus Surgical, thereby integrating Asensus’s Senhance/LUNA robotics and digital OR technologies into Karl Storz’s endoscopy and visualization portfolio.

Surgical robots are currently approved in the U.S. by the FDA and in Europe by the EU & CEA. Certification by these authorities is required for the commercialization and marketing of these devices in 27 EU nations. Surgical robots are classified as Class II devices under the U.S. FDA risk-based classification and as Class IIa (low risk) or Class IIb (high risk) in Europe. For any medical device, the process of securing the U.S. FDA 510(k) premarket approval & Europe CE Mark is a major barrier to commercializing the product and requires a considerable investment of time and resources.

Several market players are expanding their businesses by launching new products and obtaining regulatory approvals to strengthen their market positions and expand their product portfolios. For instance, in November 2024, Johnson & Johnson MedTech announced that the U.S. Food & Drug Administration (FDA) approved the OTTAVA robotic system under an investigational device exemption (IDE). This approval allows the company to begin clinical trials with this advanced clinical technology.

Analyst Perspective

The surgical robots market is expanding as healthcare providers increasingly adopt robotic-assisted procedures to improve surgical precision, enhance patient outcomes, and support minimally invasive surgery. Growth is driven by rising procedure volumes, expanding clinical applications, and advancements in artificial intelligence, imaging, visualization, and robotic instrument capabilities. At the same time, competition is shifting beyond robotic hardware toward integrated digital surgery ecosystems that combine robotics, AI-enabled planning, analytics, cloud connectivity, and lifecycle services. Established companies continue to benefit from large installed bases and strong clinical evidence, while emerging players are introducing cost-effective and modular platforms that improve accessibility. Vendors offering scalable, interoperable, and economically sustainable solutions supported by robust clinical validation, surgeon training, and recurring software and service revenues are expected to strengthen their market position as robotic-assisted surgery becomes more widely adopted.

Component Insights

The surgical robotic accessories segment accounted for the largest share of around 53.6% in 2025, owing to the recurring demand for robotic consumables, staplers, vessel sealers, scissors, and imaging accessories used in every robotic-assisted procedure. An increasing number of minimally invasive surgeries across urology, gynecology, thoracic, and general surgery further supports this segment's growth. Companies are focused on launching advanced robotic instruments and accessories with improved precision and single-port surgical capabilities. For instance, in July 2025, Intuitive Surgical received U.S. FDA clearance for its Vessel Sealer Curved instrument used in the da Vinci robotic systems. This new instrument aims to enhance its surgical precision and support the expansion of robotic-assisted surgeries, further contributing to the growth of this segment.

The surgical robotic services segment is expected to grow at the fastest CAGR during the forecast period. The segment comprises installation, system integration, maintenance, preventive servicing, software upgrades, technical support, and surgeon training provided throughout the lifecycle of robotic surgical platforms. Demand for these services is increasing as the installed base of surgical robots expands across hospitals and ambulatory surgical centers. Regular servicing ensures optimal system performance, minimizes downtime, and supports compliance with regulatory and quality standards.

Application Insights

The general surgery segment dominated the surgical robots market with the largest share of 28.7% in 2025, driven by high volumes of robotic-assisted colorectal, gastrointestinal, hepatobiliary, and hernia procedures. Robotic systems offer enhanced 3D visualization, greater instrument dexterity, improved precision, and better access to complex anatomy, supporting reduced complications, shorter hospital stays, and faster recovery. Expanding surgeon training, broader clinical indications, and continued technology improvements are further supporting adoption in general surgery.

The neurology segment is expected to register the fastest CAGR during the forecast period, supported by rising demand for minimally invasive brain and spine procedures. Robotic-assisted systems improve accuracy, reduce surgical variability, and support better outcomes in complex neurosurgical applications. Advancements in AI-enabled navigation, real-time imaging, and robotic-assisted microsurgery are further accelerating adoption. For instance, in May 2026, MMI’s Symani Surgical System was used to treat the first patient with Alzheimer’s in the FDA-approved REMIND clinical study, highlighting the expanding role of robotic precision systems in neurology and neurodegenerative disease management.

End Use Insights

The inpatient (hospital) segment dominated the surgical robots industry with a revenue share of 52.9% in 2025, as healthcare facilities are increasingly adopting robotic technology, advanced robotic instruments, and accessories to enhance medical procedures. These advanced robots offer precision, minimally invasive techniques, and improved patient outcomes. In January 2025, Prashanth Hospitals inaugurated the Institute of Robotic Surgery, introducing a medical robotic system designed for minimally invasive surgeries. With features designed to enhance precision and patient safety, and applicability across various specialties, this innovation is expected to transform how surgeries are performed.

The outpatient segment is anticipated to grow at the fastest CAGR over the forecast period. These facilities offer patients minimally invasive, highly precise surgeries, resulting in shorter recovery times and reduced healthcare costs. The growing trend towards outpatient robotic surgeries strengthens the industry's commitment to providing accessible, efficient, and patient-centric medical solutions outside traditional hospital settings. In September 2025, Memorial Care launched the advanced da Vinci 5 robotic surgical system across its hospitals, including Orange Coast Medical Center, Saddleback Medical Center, and Long Beach Medical Center in California, U.S. The platform expanded minimally invasive robotic-assisted procedures across multiple specialties, enhancing surgical precision, workflow efficiency, and patient outcomes through next-generation robotic technology.

Regional Insights

North America dominated the surgical robots market with a revenue share of 47.0% in 2025. The advancements in surgeries and healthcare facilities for various disorders are increasing the need for these systems for surgeries and treatment in North America. Diligent R&D on ergonomically designed workstations to shorten learning curves and the growing clinical adoption of new minimally invasive surgery techniques are expected to boost market demand. In March 2024, Intuitive Surgical obtained FDA 510(k) clearance for its new multiport robotic system, da Vinci 5. The system enhances the capabilities of the da Vinci Xi, which has been used in over 7 million operations worldwide, setting a new standard for minimally invasive procedures.

U.S. Surgical Robots Market Trends

The U.S. surgical robots industry dominated North America in 2025. The growing adoption of minimally invasive procedures in the country, driven by the need for shorter recovery periods, is anticipated to drive market growth. The presence of a well-developed healthcare infrastructure in the country, ongoing advancements in robots, and the presence of key market players contribute to market expansion. In April 2025, Medtronic submitted its Hugo robotic-assisted surgery system to the U.S. FDA after meeting primary safety and effectiveness endpoints in an IDE study, with the system showing a 98.5% clinical success rate.

Europe Surgical Robots Market Trends

The surgical robots industry in Europe is expected to grow significantly over the forecast period. Factors such as the presence of a well-developed healthcare infrastructure and favorable reimbursement policies that reduce the out-of-pocket expenditure of patients boost demand. Ongoing research on robots in the region is also expected to contribute to market growth over the forecast period. In July 2025 , Intuitive Surgical’s da Vinci 5 Surgical System received CE mark approval for adult and pediatric use in Europe, covering minimally invasive procedures across urologic, gynecologic, and general laparoscopic surgeries.

Germany surgical robots market is expected to grow significantly during the forecast period. The presence of high-quality healthcare infrastructure and favorable reimbursement policies is a key factor expected to drive this market. Various factors driving the market in Germany include increasing government initiatives to launch local robotics and continuous improvements in robotics and medical technology in the country.In October 2023, Johnson & Johnson MedTech launched the VELYS Robotic-Assisted Solution in the European market, initially utilized for successful Total Knee surgeries in Germany.

Asia Pacific Surgical Robots Market Trends

The Asia Pacific surgical robots industry is expected to register the fastest CAGR over the forecast period. Increasing government initiatives undertaken to encourage healthcare providers and other healthcare organizations to adopt technologically advanced medical devices & systems are a key factor expected to drive this market. In terms of adoption of technology in the Asia Pacific, Japan, Singapore, Australia, and South Korea have been adopting technology on a large scale in the healthcare sector. In contrast, Thailand, China, India, and Malaysia are the emerging markets. In May 2025, MicroPort MedBot received market approval from China’s National Medical Products Administration for its Toumai Tele-Robotic Surgical System.

The China surgical robots market is anticipated to register considerable growth during the forecast period. Increasing partnerships and the launch of products in the Chinese market are expected to drive market growth. The growing modernization of domestic production facilities is leading to the increase in the manufacturing of medical robots in China. China’s use of robotic systems combined with satellite communication represents a significant step forward in remote surgery capabilities, potentially transforming how medical care is delivered across great distances. For instance, in January 2025, Chinese surgeons successfully conducted remote surgeries using advanced robotic systems and satellite technology. This innovative approach allows surgeons to operate on patients located thousands of kilometers away, demonstrating a significant advancement in medical technology.

Latin America Surgical Robots Market Trends

The Latin America surgical robots industry is expected to witness significant growth over the forecast period. The growing prevalence of chronic diseases, the easy availability of newer technologies & robots, and the increasing prevalence of osteoporosis are among the key factors driving market growth in this region. For instance, according to the International Osteoporosis Foundation, in Latin America, the economic burden of hip fractures would cost USD 13 billion by 2050 .

The Brazil surgical robots market is anticipated to register significant growth during the forecast period. As per estimates of the World Bank, Brazil spends nearly 9.5% of its GDP in the healthcare sector and is one of the fastest-growing industries in Latin America, owing to its leading healthcare expenditure. In January 2025, MicroPort MedBot’s SkyWalker orthopedic operative robot successfully performed its inaugural total knee arthroplasty in South America at Vera Cruz Hospital in Brazil. The operation showcased accurate bone registration and osteotomy that aligned with the preoperative plans, minimizing trauma and complications.

Middle East and Africa Surgical Robots Market Trends

The Middle East and Africa surgical robots industry is anticipated to witness significant growth over the forecast period. High cancer incidence and a lack of skilled professionals in this region are boosting the need for robotic-assisted surgeries. In January 2025, King Faisal Specialist Hospital and Research Centre (KFSH&RC) successfully performed a groundbreaking medical procedure. This event marks an important advancement in healthcare services provided by the institution, which is known for its commitment to excellence in patient care and medical research.

The South Africa surgical robots market is anticipated to register substantial growth during the forecast period. There is a significant shift in the medical technology (medtech) landscape in Africa, particularly focusing on the introduction of the Da Vinci Surgical Robot and its pay-per-use equipment model. The installation of a Da Vinci robot at Busamed Gateway Private Hospital in KwaZulu-Natal in August 2024 represents a significant advancement in the accessibility of advanced medical technology in Africa. It allows healthcare facilities to utilize state-of-the-art robotic surgery without incurring the substantial capital costs typically associated with such technologies.

Key Surgical Robots Company Insights

Key participants in the surgical robots industry are focusing on devising innovative business growth strategies, such as expanding their product portfolios, partnerships and collaborations, mergers and acquisitions, and expanding their business footprints.

Key Surgical Robots Companies

The following key companies have been profiled for this study of the surgical robots market.

• Medtronic

• Intuitive Surgical

• MICROPORT SCIENTIFIC

• SS Innovations

• Stryker

• Johnson & Johnson

• Asensus Surgical US, Inc. | Part of KARL STORZ

• Distalmotion

• CMR Surgical

• Moon Surgical

• Medicaroid

• Ronovo Surgical

• Cornerstone Robotics

Competitive Benchmarking

Recent Developments

• In May 2026, Johnson & Johnson announced positive clinical study results for its OTTAVA soft-tissue robotic surgical system, highlighting advancements in robotic-assisted minimally invasive surgery.

• In April 2026, Stäubli Robotics launched the TX2-60L MedX Ready medical robot, a high-precision six-axis system designed for surgical and clinical applications, offering enhanced safety, reliability, and manual guidance for medical device integration.

• In April 2026, SS Innovations launched next-generation surgical robotic technologies, including the SSi Vimana Aero drone system and SSi Avtara humanoid platform, highlighting advancements in remote surgery, battlefield care, and mobile robotic operating environments.

• In March 2026, CMR Surgical partnered with NVIDIA to develop and train next-generation AI-powered robotic surgery systems by contributing surgical data to Open-H, an open robotics dataset, supporting faster innovation in surgical robotics.

• In February 2026, Stryker introduced the Mako RPS handheld robotic system for total knee procedures, expanding its Mako robotics portfolio and enabling robotically guided surgical precision through its SmartRobotics platform.

• In February 2026, Medtronic received U.S. FDA 510(k) clearance for the Stealth AXiS surgical system, an integrated spine surgery platform combining AI-based planning, real-time navigation, and robotic assistance.

• In September 2025, Siemens Healthineers and Stryker announced a strategic partnership to develop a robotic system for neurovascular procedures, including stroke and aneurysm treatments, aimed at improving precision and workflow efficiency.

• In July 2025, CARE Hospitals in Hyderabad introduced the AI-driven Stryker Mako Robotic System for robotic-assisted joint replacement surgeries, combining 3D CT-based planning with real-time surgical guidance.

• In June 2025, SS Innovations performed the first robotic cardiac surgery in the Americas using its SSi Mantra 3 system at Interhospital, Ecuador, strengthening the company’s global expansion in robotic-assisted surgery.

• In April 2025, Johnson & Johnson MedTech completed the first clinical cases using the OTTAVA Robotic Surgical System for gastric bypass surgery at Memorial Hermann-Texas Medical Center.

Surgical Robots Market Report Scope

Global Surgical Robots Market Segmentation

This report forecasts revenue & volume growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global surgical robots market report based on component, application, end use, and region:

• Component Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Surgical Robots

  • Surgical Robotic Accessories

  • Surgical Robotic Services

• Application Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • General Surgery

  • Gynecology

  • Urology

  • Orthopedic Surgery

    • Hip

    • Knee

    • Spine

    • Others

  • Neurology

  • Cardiac Surgery

  • Bariatric

  • Bronchoscopy/Pulmonary

  • Others

• End Use Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Inpatient

  • Outpatient

• Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The surgical robots market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing—reconciling supply-side and demand-side estimates—and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each surgical robots segment quantified using the revenue-capture definitions in the table below.

Segment Definition

Estimation Model

Market-specific Research Models:

Consensus-Based Estimates & Forecasting:

The surgical robots market presents emerging to dominant opportunities, featuring global key players such as Medtronic; Intuitive Surgical; MICROPORT SCIENTIFIC; SS Innovations; Stryker; Johnson & Johnson; Asensus Surgical US, Inc.- Part of KARL STORZ; Distalmotion; CMR Surgical; Moon Surgical; Medicaroid; Ronovo Surgical; Cornerstone Robotics. To ensure a holistic approach, the GVR research team adopted a comprehensive methodology, considering multiple companies worldwide and utilizing various variables for data accuracy.

Our methodology included:

Model 1: Commodity Flow Analysis - For public players, annual reports were referenced. For private players, premium paid data sources such as S&P Global, Crunchbase, ZoomInfo, RocketReach, etc., were used for the latest revenue insights.

Model 2: Parent Market Analysis

Model 3: Country-level Multivariate Analysis Assumptions

Model 4: Segment-level Multivariate Analysis Assumptions

Model 5: Surgical Robots Market CAGR Calculations

Commodity flow analysis was employed to track the movement of surgical robots through the value chain, from technology providers to end users. This analysis provided insights into demand generation points, intermediary roles, and ultimate consumption patterns.

Delivered Customizations

This report has been delivered with the following In-depth customizations